Wednesday, November 15, 2017 1:23:15 PM
And I am no doctor or scientist, just a business person. First thing I would do, is verify/validate the patents. Look at the history of...who created it, was it purchased from another and modified, etc...if purchased, what was it purchased for...? Having said that, I have researched this patent. It came from a French science group. They sold it to this doctor for approximately 60K USD. Why that price, I cannot tell you, why were the French selling such a life altering, flagship drug as Sunshine calls it? I don't know. Now also keep in mind, the patent was purchased from Advanomics, a private entity owned by the same people that own sunshine, just google it. Also hence the name: ADVA-27a for Advanomics. So we see, a private company purchased the patent from the French, held onto it, then sold it to themselves as a public traded company...for millions....the board of directors, same for Advanomics as Sunshine, again, google it....with no shareholder inputs, created a value, and rammed it down Sunshines throat....and mind you, a company that has never made any money...if the doc knew he owner such an amazing patent, why offer it to the public, why not develop it with private equity firms, reap huge rewards....So to date, we apparently have a flagship drug, that will cure all sorts of cancer, and be better on peoples bodies, and yet...they cant fund it properly, can't move it to the next stage of development, and I know it takes time, but if it was the flagship, next best cancer drug...a) Smarter people would have already perfected it, or b) someone would have bought it from the French for 60K, why would they spend a billion on buying Sunshine? It honestly makes no sense to me....being that no one has showed interest, I'm not the only one...plus when does a billion dollar company trade for less than a penny? And when is a billion dollar company incapable of funding it's own operation? What billion dollar company has no income? No workers? No assets?
I remain hopeful in this ordeal, but logic dictates results in the business world. If major pharmacies saw any value in this patent, they would have bought it years ago. Even if they just saw it as a possible cancer drug they would take a chance...if it didn't work out, write it off. And what about the French? If they had a life altering cancer drug....why would they sell it? I just don't buy the value of proprietary patents based on my research....
Here's the referenced patent info: http://legacy-assignments.uspto.gov/assignments/assignment-pat-30086-139.pdf
Recent SBFM News
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 09:05:31 PM
- Form PRE 14C - Other preliminary information statements • Edgar (US Regulatory) • 03/05/2024 09:37:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:05:35 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/23/2024 09:03:01 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/21/2024 09:28:39 PM
- Form PRE 14C - Other preliminary information statements • Edgar (US Regulatory) • 02/21/2024 01:24:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 10:01:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 04:39:32 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/14/2024 08:53:03 PM
- Form 424B4 - Prospectus [Rule 424(b)(4)] • Edgar (US Regulatory) • 02/14/2024 04:18:31 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/13/2024 05:15:10 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/12/2024 09:05:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/12/2024 02:04:50 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 02/09/2024 10:17:56 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 02/01/2024 09:17:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/30/2024 05:38:24 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 01/08/2024 01:10:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/07/2023 09:59:51 PM
- Sunshine Biopharma Moves Principal Office to New York City • GlobeNewswire Inc. • 12/04/2023 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 02:00:15 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 01:00:46 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/02/2023 04:18:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/20/2023 05:06:33 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 10/19/2023 04:10:36 PM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM
Avant Technologies to Implement AI-Empowered, Zero Trust Architecture in Its Data Centers • AVAI • Apr 29, 2024 8:00 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM